ArticleCancer immunology, immunotherapy : CII2026
Metformin drives HIF-1α-mediated dual metabolic reprogramming to enhance γδ T cell therapy in triple-negative breast cancer.
Xuping Qin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.